T memory stem cells in health and disease

T memory stem (TSCM) cells are a rare subset of memory lymphocytes endowed with the stem cell–like ability to self-renew and the multipotent capacity to reconstitute the entire spectrum of memory and effector T cell subsets. Cumulative evidence in mice, nonhuman primates and humans indicates that TSCM cells are minimally differentiated cells at the apex of the hierarchical system of memory T lymphocytes. Here we describe emerging findings demonstrating that TSCM cells, owing to their extreme longevity and robust potential for immune reconstitution, are central players in many physiological and pathological human processes. We also discuss how TSCM cell stemness could be leveraged therapeutically to enhance the efficacy of vaccines and adoptive T cell therapies for cancer and infectious diseases or, conversely, how it could be disrupted to treat TSCM cell driven and sustained diseases, such as autoimmunity, adult T cell leukemia and HIV-1.

[1]  B. Faubert,et al.  CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability , 2013, Proceedings of the National Academy of Sciences.

[2]  Hans Clevers,et al.  Strategies for Homeostatic Stem Cell Self-Renewal in Adult Tissues , 2011, Cell.

[3]  S. Grupp,et al.  Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies , 2016, Science Translational Medicine.

[4]  M. Delorenzi,et al.  Genome-wide RNA profiling of long-lasting stem cell-like memory CD8 T cells induced by Yellow Fever vaccination in humans , 2015, Genomics data.

[5]  A. Zajac,et al.  A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection , 2009, Science.

[6]  C. von Kalle,et al.  Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory , 2015, Science Translational Medicine.

[7]  S. Rosenberg,et al.  Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice , 2011, Clinical Cancer Research.

[8]  D. Douek,et al.  PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors. , 2014, The Journal of clinical investigation.

[9]  W. Leonard,et al.  IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. , 2008, Blood.

[10]  O. Kretz,et al.  Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming , 2016, Cell.

[11]  A. Rickinson,et al.  MHC II tetramers visualize human CD4+ T cell responses to Epstein–Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response , 2013, The Journal of experimental medicine.

[12]  G. Silvestri,et al.  Divergent CD4+ T Memory Stem Cell Dynamics in Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections , 2014, The Journal of Immunology.

[13]  Matheus C. Bürger,et al.  Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy , 2016, Nature.

[14]  Nikhil S. Joshi,et al.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. , 2007, Immunity.

[15]  I. Melero,et al.  Therapeutic vaccines for cancer: an overview of clinical trials , 2014, Nature Reviews Clinical Oncology.

[16]  V. Buchholz,et al.  Role of memory T cell subsets for adoptive immunotherapy. , 2016, Seminars in immunology.

[17]  Qing He,et al.  Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia , 2014, Science Translational Medicine.

[18]  M. Roederer,et al.  Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells , 2012, Nature Protocols.

[19]  M. Delorenzi,et al.  Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells , 2016, EBioMedicine.

[20]  John T. Chang,et al.  Cutting Edge: Asymmetric Memory T Cell Division in Response to Rechallenge , 2012, The Journal of Immunology.

[21]  M. Bevan,et al.  Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. , 2013, Immunity.

[22]  M. Delorenzi,et al.  Long-lasting stem cell–like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination , 2015, Science Translational Medicine.

[23]  S. Bicciato,et al.  IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. , 2013, Blood.

[24]  M. Kawahara,et al.  T memory stem cells are the hierarchical apex of adult T-cell leukemia. , 2015, Blood.

[25]  E. Wherry,et al.  Bone Marrow Is a Preferred Site for Homeostatic Proliferation of Memory CD8 T Cells , 2005, The Journal of Immunology.

[26]  R. Bonasio,et al.  Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. , 2005, Immunity.

[27]  D. Nixon,et al.  The CD8+ Memory Stem T Cell (TSCM) Subset Is Associated with Improved Prognosis in Chronic HIV-1 Infection , 2014, Journal of Virology.

[28]  M. Lederman,et al.  Limited HIV Infection of Central Memory and Stem Cell Memory CD4+ T Cells Is Associated with Lack of Progression in Viremic Individuals , 2014, PLoS pathogens.

[29]  Michael Kahn,et al.  Can we safely target the WNT pathway? , 2014, Nature Reviews Drug Discovery.

[30]  S. Migueles,et al.  CD4+ Memory Stem Cells Are Infected by HIV-1 in a Manner Regulated in Part by SAMHD1 Expression , 2014, Journal of Virology.

[31]  Pedro Romero,et al.  Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients. , 2011, The Journal of clinical investigation.

[32]  Joost B. Beltman,et al.  Heterogeneous Differentiation Patterns of Individual CD8+ T Cells , 2013, Science.

[33]  D. Maloney,et al.  Accepted Article Preview : Published ahead of advance online publication , 2016 .

[34]  M. Kester,et al.  Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. , 2014, Blood.

[35]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[36]  D. Speiser,et al.  Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients , 2016, Clinical Cancer Research.

[37]  D. Green,et al.  Metabolic Maintenance of Cell Asymmetry following Division in Activated T Lymphocytes , 2016, Nature.

[38]  J. Paul Robinson,et al.  Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[39]  P. Muranski,et al.  Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. , 2013, The Journal of clinical investigation.

[40]  M. Merad,et al.  Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4+ memory T Cells , 2014, Nature Communications.

[41]  C. Cancrini,et al.  In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells , 2015, Science Translational Medicine.

[42]  Hao Liu,et al.  Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma , 2008, Nature Medicine.

[43]  J. Lifson,et al.  Antiretroviral Therapy in Simian Immunodeficiency Virus-Infected Sooty Mangabeys: Implications for AIDS Pathogenesis , 2016, Journal of Virology.

[44]  David L. Porter,et al.  Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia , 2015, Science Translational Medicine.

[45]  R. Ahmed,et al.  From vaccines to memory and back. , 2010, Immunity.

[46]  L. Lefrançois,et al.  Cutting Edge: Requirement for IL-15 in the Generation of Primary and Memory Antigen-Specific CD8 T Cells1 , 2002, The Journal of Immunology.

[47]  John J. Rossi,et al.  Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells , 2009, Nucleic acids research.

[48]  S. Heimfeld,et al.  Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells , 2016, Science Translational Medicine.

[49]  J. Altman,et al.  Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.

[50]  Qingsheng Li,et al.  The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. , 2010, Immunity.

[51]  Yun Ji,et al.  Adoptively transferred effector cells derived from naïve rather than central memory CD8+ T cells mediate superior antitumor immunity , 2009, Proceedings of the National Academy of Sciences.

[52]  G. V. D. van der Windt,et al.  Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. , 2012, Immunity.

[53]  S. Jameson,et al.  Diversity in T cell memory: an embarrassment of riches. , 2009, Immunity.

[54]  E. Bonifacio,et al.  Differentiation, expansion, and homeostasis of autoreactive T cells in type 1 diabetes mellitus , 2009, Current diabetes reports.

[55]  S. Rosenberg,et al.  Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity , 2015, Journal of Virology.

[56]  T. Waldmann,et al.  Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Speiser,et al.  T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? , 2014, Nature Reviews Immunology.

[58]  Martin Pule,et al.  Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. , 2011, Blood.

[59]  F. Sallusto,et al.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.

[60]  J. Weber,et al.  IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection , 2009, Science.

[61]  F. Marincola,et al.  Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy. , 2015, The Journal of clinical investigation.

[62]  Sandra P. Calderon-Copete,et al.  T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections. , 2016, Immunity.

[63]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[64]  C. Klebanoff,et al.  Pharmacologic Induction of CD8+ T Cell Memory: Better Living Through Chemistry , 2009, Science Translational Medicine.

[65]  B. Dumitriu,et al.  Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia , 2016, The Journal of Immunology.

[66]  Qingsheng Li,et al.  A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. , 2011, Immunity.

[67]  Greg M. Delgoffe,et al.  Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8 T cell differentiation , 2016, Nature Immunology.

[68]  J. Harty,et al.  Constitutive Activation of Wnt Signaling Favors Generation of Memory CD8 T Cells , 2009, The Journal of Immunology.

[69]  Sean J. Morrison,et al.  Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life , 2008, Cell.

[70]  N. Restifo,et al.  Lineage relationship of effector and memory T cells. , 2013, Current opinion in immunology.

[71]  F. Marincola,et al.  Lineage relationship of CD8+ T cell subsets is revealed by progressive changes in the epigenetic landscape , 2015, Cellular and Molecular Immunology.

[72]  A. Santoro,et al.  Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation. , 2015, Blood.

[73]  L. Gattinoni Memory T cells officially join the stem cell club. , 2014, Immunity.

[74]  D. Pellicci,et al.  T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate. , 2015, Immunity.

[75]  M. Rep,et al.  Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.

[76]  C. Rooney,et al.  Peripheral Blood–Derived Virus-Specific Memory Stem T Cells Mature to Functional Effector Memory Subsets with Self-Renewal Potency , 2015, The Journal of Immunology.

[77]  F. Rosa Two Niches in the Bone Marrow: A Hypothesis on Life-long T Cell Memory. , 2016 .

[78]  G. Silvestri,et al.  Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques , 2016, Journal of Virology.

[79]  Mark S. Sundrud,et al.  Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. , 2015, Cancer research.

[80]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[81]  J. Mateus,et al.  Low Frequency of Circulating CD8+ T Stem Cell Memory Cells in Chronic Chagasic Patients with Severe Forms of the Disease , 2015, PLoS neglected tropical diseases.

[82]  D. Zehn,et al.  Differences in the Transduction of Canonical Wnt Signals Demarcate Effector and Memory CD8 T Cells with Distinct Recall Proliferation Capacity , 2014, The Journal of Immunology.

[83]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[84]  Alimuddin Zumla,et al.  Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[85]  Daniel Li,et al.  CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. , 2016, The Journal of clinical investigation.

[86]  Bernd Hauck,et al.  Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.

[87]  A. Zajac,et al.  IL-21 Deficiency Influences CD8 T Cell Quality and Recall Responses following an Acute Viral Infection , 2010, The Journal of Immunology.

[88]  J. Harty,et al.  Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. , 2010, Immunity.

[89]  Michael J. Bevan,et al.  The precursors of memory: models and controversies , 2009, Nature Reviews Immunology.

[90]  E. Wherry,et al.  Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells , 2002, The Journal of experimental medicine.

[91]  Mario Roederer,et al.  Single-cell technologies for monitoring immune systems , 2014, Nature Immunology.

[92]  O. Yang,et al.  HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies , 2016, Journal of Virology.

[93]  T. Waldmann,et al.  Superior T memory stem cell persistence supports long-lived T cell memory. , 2013, The Journal of clinical investigation.

[94]  D. Munn,et al.  IL-7 signaling imparts polyfunctionality and stemness potential to CD4+ T cells , 2016, Oncoimmunology.

[95]  N. Restifo,et al.  Moving T memory stem cells to the clinic. , 2013, Blood.

[96]  Hyun-Dong Chang,et al.  Memory CD8+ T cells colocalize with IL-7+ stromal cells in bone marrow and rest in terms of proliferation and transcription , 2015, European journal of immunology.

[97]  Wei-Ting Hwang,et al.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. , 2014, The New England journal of medicine.

[98]  S. Rosenberg,et al.  Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. , 2005, The Journal of clinical investigation.

[99]  Thomas Höfer,et al.  Disparate Individual Fates Compose Robust CD8+ T Cell Immunity , 2013, Science.

[100]  Mike Gough,et al.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. , 2008, The Journal of clinical investigation.

[101]  T. Kupper,et al.  The emerging role of resident memory T cells in protective immunity and inflammatory disease , 2015, Nature Medicine.

[102]  E. Rosenberg,et al.  HIV-1 persistence in CD4+ T cells with stem cell-like properties , 2014, Nature Medicine.

[103]  Sadik H. Kassim,et al.  A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response , 2014, Clinical Cancer Research.

[104]  Jiang Zhu,et al.  Host-reactive CD8+ memory stem cells in graft-versus-host disease , 2005, Nature Medicine.

[105]  R. Ahmed,et al.  Insights into human CD8+ T‐cell memory using the yellow fever and smallpox vaccines , 2011, Immunology and cell biology.

[106]  S. Steinberg,et al.  Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy , 2011, Clinical Cancer Research.

[107]  S. Rosenberg,et al.  Modulation by IL-2 of CD70 and CD27 Expression on CD8+ T Cells: Importance for the Therapeutic Effectiveness of Cell Transfer Immunotherapy1 , 2006, The Journal of Immunology.

[108]  I. Weissman,et al.  Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[109]  D. Speiser,et al.  Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. , 2005, The Journal of clinical investigation.

[110]  Joonsoo Kang,et al.  Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory , 2010, Proceedings of the National Academy of Sciences.

[111]  D. Fearon,et al.  Arrested Differentiation, the Self-Renewing Memory Lymphocyte, and Vaccination , 2001, Science.

[112]  M. Sabatino,et al.  Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies. , 2016, Blood.

[113]  David L. Porter,et al.  T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia , 2011, Science Translational Medicine.

[114]  A. Elkahloun,et al.  The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness , 2016, Science Immunology.

[115]  L. Gattinoni The dark side of T memory stem cells. , 2015, Blood.

[116]  S. Bicciato,et al.  Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation. , 2015, Blood.

[117]  Ton N. Schumacher,et al.  Adoptive cellular therapy: A race to the finish line , 2015, Science Translational Medicine.

[118]  Lei Zhang,et al.  Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer , 2012, Nature Medicine.

[119]  C. Rice,et al.  The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD 8 T Cell Response 1 , 2009 .

[120]  U. Klein,et al.  Asymmetric PI3K Signaling Driving Developmental and Regenerative Cell Fate Bifurcation. , 2015, Cell reports.

[121]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[122]  S. Rosenberg,et al.  Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  F. Marincola,et al.  Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy. , 2016, Cell metabolism.

[124]  Chih-Hao Chang,et al.  Fueling Immunity: Insights into Metabolism and Lymphocyte Function , 2013, Science.

[125]  S. Rosenberg,et al.  Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[126]  Qing He,et al.  CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia , 2013, Science Translational Medicine.

[127]  Sadik H. Kassim,et al.  Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  Xiuli Wang,et al.  Comparison of naïve and central memory derived CD8+ effector cell engraftment fitness and function following adoptive transfer , 2016, Oncoimmunology.

[129]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[130]  C. Klebanoff,et al.  Paths to stemness: building the ultimate antitumour T cell , 2012, Nature Reviews Cancer.

[131]  Christine E Brown,et al.  Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL. , 2016, Blood.

[132]  P. Muranski,et al.  Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells , 2009, Nature Medicine.

[133]  Christian Stemberger,et al.  Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapy. , 2014, Blood.

[134]  J. Harty,et al.  A Default Pathway of Memory CD8 T Cell Differentiation after Dendritic Cell Immunization Is Deflected by Encounter with Inflammatory Cytokines during Antigen-Driven Proliferation1 , 2009, The Journal of Immunology.

[135]  Christian Stemberger,et al.  Serial transfer of single-cell-derived immunocompetence reveals stemness of CD8(+) central memory T cells. , 2014, Immunity.

[136]  D. Dimitrov,et al.  Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. , 1997, Blood.

[137]  John T. Chang,et al.  Molecular regulation of effector and memory T cell differentiation , 2014, Nature Immunology.

[138]  C. Klebanoff,et al.  Sorting Through Subsets: Which T-Cell Populations Mediate Highly Effective Adoptive Immunotherapy? , 2012, Journal of immunotherapy.

[139]  F. Ennis,et al.  Human cytotoxic T-cell memory: long-lived responses to vaccinia virus , 1996, Journal of virology.

[140]  Kensuke Takada,et al.  Naive T cell homeostasis: from awareness of space to a sense of place , 2009, Nature Reviews Immunology.

[141]  Mario Roederer,et al.  The Genetic Architecture of the Human Immune System: A Bioresource for Autoimmunity and Disease Pathogenesis , 2015, Cell.

[142]  R. Rappuoli,et al.  Vaccines for the future: learning from human immunology , 2012, Microbial biotechnology.

[143]  S. Kaech,et al.  An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. , 2011, Immunity.

[144]  E. Steinhagen-Thiessen,et al.  Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study , 2015, Biogerontology.

[145]  Seth M Steinberg,et al.  T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial , 2015, The Lancet.

[146]  F. Sallusto,et al.  Opinion-decision making in the immune system: Progressive differentiation and selection of the fittest in the immune response , 2002, Nature Reviews Immunology.

[147]  M. Raffeld,et al.  Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.

[148]  Pamela A Shaw,et al.  Chimeric antigen receptor T cells for sustained remissions in leukemia. , 2014, The New England journal of medicine.

[149]  E. Rosenberg,et al.  Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties , 2015, Journal of Virology.

[150]  Dan Peer,et al.  Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles. , 2015, ACS nano.

[151]  C. Creighton,et al.  Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. , 2014, Blood.

[152]  S. Rosenberg,et al.  Telomere Length of Transferred Lymphocytes Correlates with In Vivo Persistence and Tumor Regression in Melanoma Patients Receiving Cell Transfer Therapy1 , 2005, The Journal of Immunology.

[153]  John T. Chang,et al.  Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. , 2011, Immunity.

[154]  C. Turtle,et al.  Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells. , 2012, Blood.

[155]  D. Farber,et al.  Human memory T cells: generation, compartmentalization and homeostasis , 2013, Nature Reviews Immunology.

[156]  S. Rosenberg,et al.  Transfer Therapy Cancer Regression in Patients Receiving Cell Lymphocyte Clonotypes Correlates with Cutting Edge: Persistence of Transferred , 2022 .

[157]  F. Marincola,et al.  A human memory T-cell subset with stem cell-like properties , 2011, Nature Medicine.